Literature DB >> 3304691

Site-specific covalent binding of stilbene-type and steroidal estrogens to tubulin following metabolic activation in vitro.

B Epe, J Hegler, M Metzler.   

Abstract

Both the steroidal estrogen, 2-hydroxy estradiol, and the stilbene-type estrogen, diethylstilbestrol, bind covalently and selectively to the C-terminal domain of beta-tubulin after peroxidative activation in vitro. The binding probably has to be attributed to quinonoid metabolites, as estrogens such as estradiol and hexestrol, which are unable to form quinones under these conditions, fail to bind. Albumin is not simultaneously modified, demonstrating the selectivity of the binding. The observed protein binding is discussed with respect to estrogen-induced aneuploidy and neoplastic cell transformation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304691     DOI: 10.1093/carcin/8.9.1271

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

Review 1.  Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals.

Authors:  T Tsutsui; J C Barrett
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

Review 2.  Role of prostaglandin-H synthase in mediating genotoxic and carcinogenic effects of estrogens.

Authors:  G H Degen
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

3.  Covalent binding of reactive estrogen metabolites to microtubular protein as a possible mechanism of aneuploidy induction and neoplastic cell transformation.

Authors:  B Epe; U Harttig; H Stopper; M Metzler
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

4.  Site-specific covalent modifications of human insulin by catechol estrogens: Reactivity and induced structural and functional changes.

Authors:  Ming-Chun Ku; Chieh-Ming Fang; Juei-Tang Cheng; Huei-Chen Liang; Tzu-Fan Wang; Chih-Hsing Wu; Chiao-Chen Chen; Jung-Hsiang Tai; Shu-Hui Chen
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.